Afelimomab

Also known as: MAK 195F

Description

Afelimomab is an anti-TNFα monoclonal antibody. Administration of afelimomab reduces the concentration of interleukin-6 in patients with sepsis, but reduces mortality only marginally.

Medicine classification

ATC Code
Title
Class
L04AB03
Afelimomab
L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AB Tumor necrosis factor alpha (TNF-α) inhibitors

Unique Ingredient Identifier (UNII)

6SC756X51V - AFELIMOMAB

CAS Registry Number

156227-98-4 - afelimomab

Usage: Next >